| | | | |
CUSIP NO. 917047102 | | 13D | | Page 4 of 7 Pages |
On May 26, 2021, Mr. Cherken acquired 20,000 Common Shares through an exercise of stock options granted to him for his service as director of the Company.
On June 2, 2021, Mr. Cherken acquired 8,300 Common Shares through the vesting of Restricted Stock Units granted to him for his service as director of the Company.
On June 6, 2022, Mr. Cherken acquired 3,900 Common Shares through the vesting of Restricted Stock Units granted to him for his service as director of the Company.
On July 28, 2022, Mr. Cherken acquired beneficial ownership of 711,735 Common Shares as trustee of a trust that received such shares as a beneficiary of a Grantor Retained Annuity Trust.
Mr. Cherken paid the exercise price for each of the stock options described above with the proceeds of margin loans from the Charles Schwab Corporation on customary terms, none of which loans were secured by any Common Shares of the Company. All other Common Shares reported in this Item were received without consideration.
Item 4. Purpose of Transaction
Item 4 of the Statement is hereby amended and restated by adding the following paragraphs following the end of the previous disclosure:
As a director of the Company, Mr. Cherken is treated as a controlling person of the Company for purposes of this Statement.
Mr. Cherken presently has no plans or proposals which relate to or would result in any action enumerated in subparagraphs (b) through (j) of the instructions for Item 4 of Schedule 13D.
Pursuant to its terms, Mr. Cherken’s 2020 Harry S. Cherken, Jr. Grantor Retained Annuity Trust (the “2020 GRAT”) is required to make an annuity payment on or before October 27, 2022, upon which the 2020 GRAT will terminate. Upon termination, the remaining assets in the 2020 GRAT will be transferred to a trust of which certain members of Mr. Cherken’s family are beneficiaries.
Item 5. Interest in Securities of the Issuer.
| (a) | Amount Beneficially Owned. |
9,394,689 Common Shares
10.2% (based on 92,173,342 Common Shares outstanding as of July 28, 2022, as provided by the issuer, plus 80,000 common shares subject to presently exercisable options)